<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36817925</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>High prevalence of persistent symptoms and reduced health-related quality of life 6 months after COVID-19.</ArticleTitle><Pagination><StartPage>1104267</StartPage><MedlinePgn>1104267</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1104267</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1104267</ELocationID><Abstract><AbstractText Label="BACKGROUND">The long-term sequelae after COVID-19 constitute a challenge to public health and increased knowledge is needed. We investigated the prevalence of self-reported persistent symptoms and reduced health-related quality of life (HRQoL) in relation to functional exercise capacity, 6 months after infection, and explored risk factors for COVID-19 sequalae.</AbstractText><AbstractText Label="METHODS">This was a prospective, multicenter, cohort study including 434 patients. At 6 months, physical exercise capacity was assessed by a 1-minute sit-to-stand test (1MSTST) and persistent symptoms were reported and HRQoL was evaluated through the EuroQol 5-level 5-dimension (EQ-5D-5L) questionnaire. Patients with both persistent symptoms and reduced HRQoL were classified into a new definition of post-acute COVID syndrome, PACS+. Risk factors for developing persistent symptoms, reduced HRQoL and PACS+ were identified by multivariable Poisson regression.</AbstractText><AbstractText Label="RESULTS">Persistent symptoms were experienced by 79% of hospitalized, and 59% of non-hospitalized patients at 6 months. Hospitalized patients had a higher prevalence of self-assessed reduced overall health (28 vs. 12%) and PACS+ (31 vs. 11%). PACS+ was associated with reduced exercise capacity but not with abnormal pulse/desaturation during 1MSTST. Hospitalization was the most important independent risk factor for developing persistent symptoms, reduced overall health and PACS+.</AbstractText><AbstractText Label="CONCLUSION">Persistent symptoms and reduced HRQoL are common among COVID-19 survivors, but abnormal pulse and peripheral saturation during exercise could not distinguish patients with PACS+. Patients with severe infection requiring hospitalization were more likely to develop PACS+, hence these patients should be prioritized for clinical follow-up after COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Ahmad, Edin, Granvik, Kumm Persson, Tevell, M&#xe5;nsson, Magnuson, Marklund, Persson, Kauppi, Ahlm, Forsell, Sundh, Lange, Cajander and Normark.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Irma</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edin</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical and Perioperative Sciences, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granvik</LastName><ForeName>Christoffer</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumm Persson</LastName><ForeName>Lowa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Surgical and Perioperative Sciences, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tevell</LastName><ForeName>Staffan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Karlstad Hospital, Karlstad, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Research and Education, Region V&#xe4;rmland, Karlstad, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe5;nsson</LastName><ForeName>Emeli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research, Region V&#xe4;stmanland-Uppsala University, V&#xe4;stmanland Hospital V&#xe4;ster&#xe5;s, V&#xe4;ster&#xe5;s, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnuson</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, School of Medical Sciences, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marklund</LastName><ForeName>Ingela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centre for Clinical Research and Education, Region V&#xe4;rmland, Karlstad, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Medicine and Rehabilitation, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Persson</LastName><ForeName>Ida-Lisa</ForeName><Initials>IL</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kauppi</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahlm</LastName><ForeName>Clas</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsell</LastName><ForeName>Mattias N E</ForeName><Initials>MNE</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sundh</LastName><ForeName>Josefin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cajander</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, Faculty of Medicine and Health, &#xd6;rebro University, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Normark</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">EQ-5D</Keyword><Keyword MajorTopicYN="N">PACS</Keyword><Keyword MajorTopicYN="N">Post COVID-19 condition (PCC)</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID syndrome (PACS)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36817925</ArticleId><ArticleId IdType="pmc">PMC9932930</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1104267</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roffman CE, Buchanan J, Allison GT. Charlson comorbidities index. J Physiother. (2016) 62:171. 10.1016/j.jphys.2016.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphys.2016.05.008</ArticleId><ArticleId IdType="pubmed">27298055</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)&#x2013;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. (2009) 42:377&#x2013;81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kataoka K, et al. . A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J. (2010) 36:1067&#x2013;72. 10.1183/09031936.00152609</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00152609</ArticleId><ArticleId IdType="pubmed">20413545</ArticleId></ArticleIdList></Reference><Reference><Citation>EQ-5D-5L &#x2013; EQ-5D. Available online at: https://euroqol.org/eq-5d-instruments/eq-5d-5l-about/ (accessed February 10, 2022).</Citation></Reference><Reference><Citation>Bohannon RW, Crouch R. 1-minute sit-to-stand test: systematic review of procedures, performance, and clinimetric properties. J Cardiopulm Rehabil Prev. (2019) 39:2&#x2013;8. 10.1097/HCR.0000000000000336</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCR.0000000000000336</ArticleId><ArticleId IdType="pubmed">30489442</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez-Cort&#xe9;s R, Rivera-Lillo G, Arias-Campoverde M, Soto-Garc&#xed;a D, Garc&#xed;a-Palomera R, Torres-Castro R. Use of sit-to-stand test to assess the physical capacity and exertional desaturation in patients post COVID-19. Chron Respir Dis. (2021) 18:1479973121999205. 10.1177/1479973121999205</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1479973121999205</ArticleId><ArticleId IdType="pmc">PMC7923980</ArticleId><ArticleId IdType="pubmed">33645261</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, et al. . A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. (2020) 20:e192&#x2013;7. 10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. . Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. (2022) 28:657&#x2013;66. 10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al. . Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. eClinicalMedicine. (2022) 51. 10.1016/j.eclinm.2022.101549</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al. . Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. (2021) 325:1525&#x2013;34. 10.1001/jama.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiolliere F, Falandry C, Allaouchiche B, Geoffray V, Bitker L, Reignier J, et al. . Intensive care-related loss of quality of life and autonomy at 6 months post-discharge: does COVID-19 really make things worse? Crit Care. (2022) 26:94. 10.1186/s13054-022-03958-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-03958-6</ArticleId><ArticleId IdType="pmc">PMC8978758</ArticleId><ArticleId IdType="pubmed">35379312</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. (2022) 604:697&#x2013;707. 10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Rau A, Schroeter N, Blazhenets G, Dressing A, Walter LI, Kellner E, et al. . Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Brain. (2022) 145:3203&#x2013;13. 10.1093/brain/awac045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac045</ArticleId><ArticleId IdType="pmc">PMC9214163</ArticleId><ArticleId IdType="pubmed">35675908</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J, et al. . Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. (2022) 185:2452&#x2013;68. 10.1016/j.cell.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SK, Olde Hartman TC, Rosmalen JG. Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. (2022) 400:452&#x2013;61. 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Kim SW, Chang HH, Kwon KT, Bae S, Hwang S. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis. (2022) 22:93. 10.1186/s12879-022-07062-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07062-6</ArticleId><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, Bonvanie IJ, Olde, Hartman TC, Monden R, Rosmalen JGM. Gender and sex independently associate with common somatic symptoms and lifetime prevalence of chronic disease. Soc Sci Med. (2020) 253:112968. 10.1016/j.socscimed.2020.112968</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.112968</ArticleId><ArticleId IdType="pubmed">32272303</ArticleId></ArticleIdList></Reference><Reference><Citation>Costeira R, Lee KA, Murray B, Christiansen C, Castillo-Fernandez J, Lochlainn M, et al. . Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study. PLoS ONE. (2021) 16:e0257051. 10.1371/journal.pone.0257051</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257051</ArticleId><ArticleId IdType="pmc">PMC8432854</ArticleId><ArticleId IdType="pubmed">34506535</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk - a signal to address sex hormones and women's health. Lancet Reg Health. (2021) 11. 10.1016/j.lanepe.2021.100242</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai R, Singh R, Azim A, Agarwal A, Mishra P, Singh PK. Impact of critical illness on quality of life after intensive care unit discharge. Ind J Crit Care Med. (2020) 24:299&#x2013;306. 10.5005/jp-journals-10071-23433</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-23433</ArticleId><ArticleId IdType="pmc">PMC7358873</ArticleId><ArticleId IdType="pubmed">32728319</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstr&#xf6;m K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res. (2001) 0:621&#x2013;35. 10.1023/A:1013171831202</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1013171831202</ArticleId><ArticleId IdType="pubmed">11822795</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstr&#xf6;m K, Teni FS, Gerdtham U-G, Leidl R, Helgesson G, Rolfson O, et al. . Experience-based Swedish TTO and VAS value sets for EQ-5D-5L Health States. Pharmacoeconomics. (2020) 38:839&#x2013;56. 10.1007/s40273-020-00905-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-020-00905-7</ArticleId><ArticleId IdType="pubmed">32307663</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite, Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, et al. . Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study. J Neurol. (2022) 269:587&#x2013;96. 10.1007/s00415-021-10735-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladlow P, O'Sullivan O, Houston A, Barker-Davies R, May S, Mills D, et al. . Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations. Heart Rhythm. (2022) 19:613&#x2013;20. 10.1016/j.hrthm.2021.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2021.12.005</ArticleId><ArticleId IdType="pmc">PMC8656177</ArticleId><ArticleId IdType="pubmed">34896622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad I, Edin A, Granvik C, Kumm, Persson L, Tevell S, et al. . High Prevalence of Persistent Symptoms and Reduced Health-Related Quality of Life 6 Months After COVID-19. Available online at: https://ssrn.com/abstract=4264310 (accessed November 21, 2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932930</ArticleId><ArticleId IdType="pubmed">36817925</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>